ICLR
ICON plc
NASDAQ · Healthcare · Medical - Diagnostics & Research · IE
$164.11
−3.28%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$168.54
From 52W high−19.13%
Volume1.12M
Market cap$12.66B
P/E (TTM)38.3x
P/S (TTM)1.5x
Div yield—
Key dataSep 18, 2026
Open
$168.54
From 52W high
−19.13%
Volume
1.12M
Market cap
$12.66B
ValuationView details →
P/E (Fwd)
14.7x
EV/EBITDA
12.2x
P/E (TTM)
38.3x
RSI (14)
47.1
MomentumView details →
1D Return
−3.28%
YTD Return
−9.73%
SummaryUpdated Jun 1, 2026
ICON Public Limited Company (NASDAQ:ICLR) is a Dublin-based clinical research organization that was founded in 1990 and went public in 1998. The company provides comprehensive outsourced development and commercialization services to pharmaceutical, biotechnology, and medical device companies worldwide. ICON has grown significantly through strategic acquisitions, most notably its 2021 merger with PRA Health Sciences, which transformed it into one of the world's largest contract research organizations. Today, ICON operates globally with a particular strength in supporting clinical trials from early-phase development through post-market surveillance.
Similar companies
Latest newsMore news →
Alkermes plc appointed Anne C. Whitaker to its board of directors effective September 14, 2026, with an initial equity award target value of $600,000.4d agoA coalition of real estate, builder and housing nonprofits launched the national public awareness campaign "Let America Build" to advance pro-building policies as communities implement the 21st Century ROAD to Housing Act.5d ago